GlassScriptPhysician profile
Pramote Malasitt
NPI 1275825259
$7,609.05
in general payments reported to CMS, 2019-2025
7 companies · $280 in 2025
The $280 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,219 · 2021: $750 · 2022: $120 · 2023: $1,154 · 2024: $85.96 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $879 · Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $879.24 |
| Food and Beverage | $640.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,149.21 | 2019-2023 | |
| Encore Medical, LP | $2,048.72 | 2019-2021 | |
| Depuy Synthes Sales INC. | $547.28 | 2022-2025 | Na, Inhance, Va-Lcp |
| Fortis Surgical, LLC | $540.72 | 2023-2024 | |
| Pacira Cryotech Incorporated | $117.44 | 2019 | |
| Aesculap Biologics, LLC | $116.11 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $89.57 | 2023 | Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pramote Malasitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.